Literature DB >> 2974757

The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma.

M Kjaer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2974757     DOI： 10.1016/0305-7372(88)90003-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  2 in total

1.  Spontaneous regression of metastatic renal cell carcinoma following palliative irradiation of the primary tumour.

Authors:  M P MacManus; R J Harte; S Stranex
Journal:  Ir J Med Sci       Date:  1994-10       Impact factor: 1.568

2.  Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.

Authors:  C M van Herpen; R L Jansen; W H Kruit; K Hoekman; G Groenewegen; S Osanto; P H De Mulder
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.